AXS Investments’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,774
| Closed | -$135K | – | 335 |
|
|
2023
Q4 | $135K | Sell |
1,774
-1,175
| -40% | -$89.6K | 0.03% | 317 |
|
|
2023
Q3 | $204K | Sell |
2,949
-13,991
| -83% | -$969K | 0.05% | 260 |
|
|
2023
Q2 | $1.6M | Buy |
16,940
+14,778
| +684% | +$1.39M | 0.43% | 59 |
|
|
2023
Q1 | $179K | Sell |
2,162
-14,961
| -87% | -$1.24M | 0.06% | 218 |
|
|
2022
Q4 | $1.28M | Buy |
17,123
+14,701
| +607% | +$1.1M | 0.46% | 62 |
|
|
2022
Q3 | $200K | Sell |
2,422
-468
| -16% | -$38.6K | 0.08% | 201 |
|
|
2022
Q2 | $275K | Sell |
2,890
-1,056
| -27% | -$100K | 0.1% | 191 |
|
|
2022
Q1 | $465K | Sell |
3,946
-1,551
| -28% | -$183K | 0.19% | 88 |
|
|
2021
Q4 | $712K | Buy |
+5,497
| New | +$712K | 0.17% | 97 |
|
|
2021
Q3 | – | Sell |
-9,674
| Closed | -$1M | – | 144 |
|
|
2021
Q2 | $1M | Buy |
9,674
+2,121
| +28% | +$220K | 0.31% | 77 |
|
|
2021
Q1 | $632K | Buy |
+7,553
| New | +$632K | 0.22% | 90 |
|